1. Home
  2. Labeler Index
  3. Sanofi-aventis U.s. Llc
  4. 0024-5862
  5. NDC Package Code: 0024-5862-01 Mozobil

NDC Package 0024-5862-01 Mozobil

Plerixafor Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0024-5862-01
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 1.2 mL in 1 VIAL, SINGLE-USE
Product Code:
0024-5862
Proprietary Name:
Mozobil
Non-Proprietary Name:
Plerixafor
Substance Name:
Plerixafor
Usage Information:
Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant. Stem cells, which are found mainly in the bone marrow, turn into red blood cells, white blood cells, and platelets. Plerixafor is used to help stem cells move from the bone marrow to the bloodstream so that the cells can be collected and stored. The stem cells are then infused back into the patient after chemotherapy or radiation.
11-Digit NDC Billing Format:
00024586201
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 828700 - plerixafor 24 MG in 1.2 ML Injection
  • RxCUI: 828700 - 1.2 ML plerixafor 20 MG/ML Injection
  • RxCUI: 828700 - plerixafor 24 MG per 1.2 ML Injection
  • RxCUI: 828703 - Mozobil 24 MG in 1.2 ML Injection
  • RxCUI: 828703 - 1.2 ML plerixafor 20 MG/ML Injection [Mozobil]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sanofi-aventis U.s. Llc
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • PLERIXAFOR 24 mg/1.2mL
    • Pharmacologic Class(es):
  • Hematopoietic Stem Cell Mobilizer - [EPC] (Established Pharmacologic Class)
  • Increased Hematopoietic Stem Cell Mobilization - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    NDA022311
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    09-01-2013
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0024-5862-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00024586201J2562Plerixafor injection1 MG1.212424

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0024-5862-01?

    The NDC Packaged Code 0024-5862-01 is assigned to a package of 1 vial, single-use in 1 carton / 1.2 ml in 1 vial, single-use of Mozobil, a human prescription drug labeled by Sanofi-aventis U.s. Llc. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 0024-5862 included in the NDC Directory?

    Yes, Mozobil with product code 0024-5862 is active and included in the NDC Directory. The product was first marketed by Sanofi-aventis U.s. Llc on September 01, 2013 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0024-5862-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0024-5862-01?

    The 11-digit format is 00024586201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20024-5862-015-4-200024-5862-01